Pelaia, G., Maselli, R., & Gallelli, L. (2014). Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium. Multidisciplinary Respiratory Medicine, 9(1). https://doi.org/10.4081/mrm.2014.399